Pharmaceuticals, Biotechnology and Life Sciences
New Film Highlights Company Commitment to Transforming RNAi Therapeutics LandscapeREDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Codexis, Inc.…
Company poised to accelerate accrual in all clinical programs as it activates numerous sites across multiple U.S. cities and abroad…
NEW YORK, July 30, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
SYFOVRE reduced nonsubfoveal GA lesion growth by up to 45% between Months 24-30 compared to projected sham in the GALE…
Additional analyses support consistent protection from vision loss Annexon to engage with regulatory agencies to determine optimal path forward for…
No indication that drug product or manufacturing issues contributed to rare events of retinal vasculitisConfirmed seven total events of non-occlusive/occlusive…
89% and 84% of patients were maintained on ≥12- and ≥16-week dosing intervals, respectively, throughout the two-year period, while sustaining their…
4D-150 clinical efficacy endpoints for evaluable patients in all three cohorts (n=14) at 36 weeks Table for 4D-150 clinical efficacy…
Press release29 July 2023 FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Brussels Contact: Eric Nys, day-to-day management,…
LONDON and NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an…